Bylece kilo verme srelerinde ve vcut kompozisyonunu iyiletirme hedeflerinde destekleyici rol oynar
HUBERMAN: So unlike your brain cells that for instance, after about age 25, you're not adding or deleting many brain cells, at least provided there's no injury or nerve degenerative disease
The pilot data is encouraging enough to justify continued research, but not yet sufficient to recommend these interventions as standard practice
Tirzepatide actually activates both GLP-1 and GIP receptors, making it a dual-acting medication with a somewhat stronger effect on the digestive system
Soon, these drugs may also have demonstrable ROI
in late 2025 and a second following in April 2026, the market is opening up to millions of people who might have hesitated before